Recently, ARHGAP17, a Cdc42-specific GAP, was identified as a negative regulator of invadopodia in breast cancer cells by shRNA screening for Rho GAPs (Kreider-Letterman et al., 2023). Here, ARHGAP17 is linked to breast cancer.